Cargando…
Anti-HBc IgM and anti-delta screening by EIA method.
The clinical value of an enzyme-linked immunosorbent assay (ELISA) for the detection of anti-HBc IgM was evaluated by testing 202 sera from acute viral hepatitis B (AVHB), hepatitis B (HB), chronic hepatitis (CAH), chronic liver disease (CLD), cirrhosis, primary hepatoma, HBsAg carrier, acute viral...
Autores principales: | Kim, J. S., Kim, J. M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Korean Academy of Medical Sciences
1986
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3053606/ https://www.ncbi.nlm.nih.gov/pubmed/3077604 |
Ejemplares similares
-
Anti-HDV IgM as a Marker of Disease Activity in Hepatitis Delta
por: Wranke, Anika, et al.
Publicado: (2014) -
Hepatitis B Core IgM antibody (anti-HBcIgM) among hepatitis B Surface antigen (HBsAg) negative blood donors in Nigeria
por: Japhet, Margaret Oluwatoyin, et al.
Publicado: (2011) -
Competition between Serum IgG, IgM, and IgA Anti-Glycan Antibodies
por: Muthana, Saddam M., et al.
Publicado: (2015) -
Evaluation of an immunochromatographic assay for the detection of anti-hepatitis A virus IgM
por: Lee, Hyeok-Jin, et al.
Publicado: (2010) -
Anti-glycan IgM repertoires in newborn human cord blood
por: Xia, Li, et al.
Publicado: (2019)